In Other News

• Genetic Marker Predicts Early Heart Failure in Pulmonary Arterial Hypertension

• Genomic Subtyping Assays Identify High-Risk Early-Stage Breast Cancers

• Open Multi-Omics Platform Identifies Prognostic Subtypes in Blood Cancers

• AI Tool Predicts Chemotherapy Response in Small Cell Lung Cancer

• Next Generation Automated Analyzers Increase Throughput for Clinical Chemistry and Electrolyte Testing

• Blood Biomarker Supports Risk Stratification in Lynch Syndrome

• GRAIL Partners with Epic to Integrate Multi-Cancer Test into EHR

• Global Partnership Aims to Streamline NGS Tumor Profiling in Oncology Trials

• cfDNA Methylation Assay Enables Multi-Disease Detection from Single Blood Sample

• Rapid Point-of-Care RT-PCR Test Differentiates Influenza A/B and SARS-CoV-2 in Minutes

• Study Links Midlife Vitamin D to Lower Tau in Alzheimer's

• Tumor-Specific Biomarker Predicts Neoadjuvant Immunotherapy Response in Gastric Cancer

• AI-Powered Digital Workflow Standardizes Bone Marrow Aspirate Morphology

• International Consensus Standardizes Tumor Microbiota Detection and Reporting

• Blood Metabolite Test Detects Early Cognitive Decline

• Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy

• ctDNA MRD Test Identifies Breast Cancer Patients Who May Avoid Surgery

• WGS MCED Assay Demonstrates Rising Sensitivity and High Specificity

• Newly Identfied Genetic Variants in MND Support Prognosis and Family Testing

• Blood-Based ctDNA Test Enhances Risk Assessment in HPV-Related Throat Cancer

• International Consensus Standardizes Tumor Microbiota Detection and Reporting

• Antibody Blood Test Identifies Active TB and Distinguishes Latent Infection

• RNA Profiling Uncovers Therapeutic Targets in Solid Tumors